Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices

Charles E Edmiston1, Michael P Goheen, Gary R Seabrook

  • 1Division of Vascular Surgery, Medical College of Wisconsin, 9200 West Wisconsin Ave., Milwaukee, WI 53226, USA. edmiston@mcw.edu

Abstract

Insights

Daptomycin, rifampin, and linezolid effectively eradicated staphylococcal adherence to biomedical devices. These antibiotics showed faster and greater efficacy than vancomycin, gentamicin, or ceftriaxone in combating device-associated infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Biomaterials Science

Background:

  • Staphylococcal infections on biomedical devices are challenging due to biofilm formation and antimicrobial resistance.
  • Effective treatment strategies are crucial for managing these recalcitrant infections.

Purpose of the Study:

  • To evaluate the efficacy of six antimicrobial agents against biofilm-forming staphylococci on biomedical devices.
  • To compare the speed and effectiveness of different antibiotics in eradicating bacterial adherence.

Main Methods:

  • Utilized an antibiotic-lock model (ALM) and vascular graft models (Dacron, ePTFE) with five clinical staphylococcal strains.
  • Assessed bacterial adherence reduction at multiple time points (1, 2, 4, 7, 10 days) post-antibiotic exposure.

Main Results:

  • Daptomycin, rifampin, and linezolid demonstrated superior efficacy in eradicating staphylococcal adherence across tested devices.
  • These agents were significantly faster in reducing bacterial adherence compared to vancomycin, gentamicin, and ceftriaxone.
  • Ceftriaxone showed limited efficacy in eradicating staphylococcal adherence from ePTFE and Dacron grafts.

Conclusions:

  • Daptomycin, rifampin, and linezolid are highly effective against staphylococcal adherence on biomedical devices.
  • Further clinical studies are recommended to confirm the efficacy of daptomycin and linezolid for device-associated infections.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Bacterial Signaling01:30

Bacterial Signaling

Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...